UNSPSC 51113400: Alkylating agent carboxylic acids

This classification denotes organic compounds containing the carboxy group (-COOH), substances called carboxylic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term ALKYLATING AGENT CARBOXYLIC ACIDS.

UNSPSC 51113400 Alkylating agent carboxylic acids is a Class code that currently shows minimal alignment with active state and local procurement. The single recent opportunity posted under this code is the Texas Health and Human Services Commission's Request for Information HHS0017013 (RFI), issued April 3, 2026, which solicits vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The RFI seeks information about vendors' experience with direct contracting for pharmaceutical products between state agencies and manufacturers outside traditional pharmacy benefit manager, group purchasing organization, and wholesaler channels. The RFI requests vendor responses regarding capacity to negotiate net pricing models without rebates, implement value-based or outcomes-based agreements, and fulfill product volume requirements through dedicated pharmacy partners or specialized channels. This is a market intelligence gathering phase rather than a formal procurement solicitation with binding evaluation criteria, awards, or budget commitments.

The code shows activity only in Texas at present, limited to the single RFI from the state health agency. The RFI does not specify set-aside designations, disadvantaged enterprise restrictions, funding allocations, or award values; it functions as an exploratory mechanism to inform Texas HHS's future procurement strategy and program design before issuing a formal RFP. Given the abstract nature of the UNSPSC category name and the limited recent activity under it, pursuit of opportunities in this code should be contingent on direct vendor engagement with Texas HHS or monitoring for downstream formal solicitations that may follow this RFI phase.